Intravenous and oral ciprofloxacin versus intravenous ceftazidime for the treatment of severe urinary tract infections

Diagnostic Microbiology and Infectious Disease

Volumn 13, Issue 2, 1990, Pages 161-163

  Childs, Stacy J ^a  

^a Southeastern Solar Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; CIPROFLOXACIN;

CONFERENCE PAPER; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; URINARY TRACT INFECTION;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; CEFTAZIDIME; CIPROFLOXACIN; COMPARATIVE STUDY; FEMALE; HUMAN; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGE; RANDOM ALLOCATION; SUPPORT, NON-U.S. GOV'T; URINARY TRACT INFECTIONS;

EID: 0025296564     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/0732-8893(90)90101-Z     Document Type: Conference Paper

References (2)

1. Ciprofloxacin: an update on clinical experience
2. Economic impact of oral ciprofloxacin: a pharmacist's perspective